Golden Anniversary for Greiner Bio-One

Greiner Bio-One was established in 1963 with the opening of a production center for laboratory products in Nürtingen, Germany under the name Greiner Labortechnik.  In 1974, manufacturing of Petri Dishes with surfaces for cell cultivation began in Austria. In 1976 new locations were acquired with a sales office in the Netherlands and a partnership in Spain.

The idea of collecting blood with the vacuum originated in the 1940’s. However, it was Greiner Labortechnik in the 1980‘s who didn‘t have just the idea, but also the technological competence to be able to manufacture the first evacuated blood collection system with safety cap made from plastic that was capable of keeping a vacuum for 18 months. The Vacuette range for specimen collection systems was born. 

In 1988, one of the most modern injection moulding plants was built covering 16,000 ft² in Frickenhausen. The growth of Greiner Labortechnik continued in the 80s and 90s with the opening of additional sales branches in Belgium and France (1988), U.K. (1989), Japan (1990) and the USA (1995) and the establishment of new production centers in Austria (1992) and Hungary (1996). 

Greiner Labortechnik made the leap from research in high throughput screening during the years 1997 and 1998 into the further development of microplates. The 96-well plate, which is still in use, was developed by Greiner as well as the 384-well plate and the much denser 1536-well plate. 

With the beginning of the new millennium, Greiner Labortechnik decided to invest in a new modern production facility in the United States in Monroe, North Carolina. 

In 2001, Greiner Labortechnik became Greiner Bio-One International AG. In the following years new safety products for the protection from needlestick injuries had been placed on the market successfully. In combination with the Vacuette Premium  Tubes with a unique safety twist cap, healthcare workers at the ward and in the lab are protected from a potential infection risk.  

Over the past ten years Greiner Bio-One has specialised additionally in the development of new molecular biological analysis methods. This includes the DNA-chip, a key technology which makes it possible to unmistakably identify bacteria or viruses in biological and pharmaceutical research.  

The company launched the DNA arrays PapilloCheck for the prevention of cervical cancer, CarnoCheck for food analysis and CytoInspect, a mycoplasma test kit. 

The Vacuette Tube-Touch Safety Holder is the latest innovation. This passive activation safety product was presented at this year’s AACC tradeshow in Houston, Texas. The safety mechanism is activated automatically when the first blood collection tube is inserted in the holder. This “next generation product” incorporates passive technology and handling comfort. 

With more than 1,700 employees and with seven production locations (Austria, Germany, Hungary, USA, Brazil and Thailand) as well as 24 sites in addition to our international distribution partners, Greiner Bio-One is represented in more than 100 countries worldwide. This ensures on-site customer care, quick deliveries and uncomplicated service. 

In 2013 GBO celebrated half a century since its grounding. This means 50 years of experience in the development and production of high quality products. The unique combination of tradition and innovation should be a firm basis for a successful future together with our worldwide customers.

Source: Greiner Bio One

28 December 2013